4//SEC Filing
Herberts Curt A. III 4
Accession 0001209191-18-025170
CIK 0001001233other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:16 PM ET
Size
9.8 KB
Accession
0001209191-18-025170
Insider Transaction Report
Form 4
Herberts Curt A. III
Senior VP & CBO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2018-04-13−8,163→ 3,750 totalExercise: $14.07Exp: 2024-12-10→ Common Stock (8,163 underlying) - Exercise/Conversion
Common Stock
2018-04-13$14.07/sh+8,163$114,853→ 22,788 total - Sale
Common Stock
2018-04-13$20.00/sh−8,163$163,260→ 14,625 total
Footnotes (3)
- [F1]All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- [F2]Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date.
- [F3]One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 11, 2014 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001691262
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:16 PM ET
- Size
- 9.8 KB